Abstract:Globally, preterm birth (PTB) is a primary cause of mortality and morbidity in infants, with PTB rates increasing worldwide over the last two decades. Biomarkers for accurate early prediction of PTB before the clinical event do not currently exist. Given their roles in the development and progression of many disease states, there has been increasing interest in the utility of microRNAs (miRNAs) as early biomarkers for pregnancy-related disorders, including PTB. The present study was designed to examine potential differences in miRNA abundances in maternal plasma from mothers with infants born following a moderate to late (28-36 weeks' gestation, n = 54) spontaneous PTB (SPTB) compared to mothers with matched term infants (n = 54). Maternal plasma collected at 15 weeks' gestation were utilised from the Auckland and Adelaide cohorts from the Screening for Pregnancy Endpoints (SCOPE) study. miRNAs in plasma were quantified using the NanoString nCounter expression panel (800 miRNAs). The top four most abundant miRNAs were significantly decreased in the plasma of mothers in the SPTB group with results consistent across both cohorts and pathway analysis was undertaken to examine the biological processes linked to the dysregulated miRNAs. The top candidate miRNAs (miRs-451a, -223-3p, let-7a-5p, and -126-3p) were linked to gene pathways associated with inflammation, apoptosis, and mitochondrial biogenesis. Moreover, miRNAs were consistently less abundant in the plasma of mothers of preterm infants across both sites, suggesting potential global dysregulation in miRNA biogenesis. This was supported by a significant downregulation in expression of key genes that are involved in miRNA biogenesis (DROSHA, DICER, and AGO2) across both sites in the SPTB group. In summary, the present study has identified miRNAs in maternal plasma that may provide predictive utility as early biomarkers for the risk of later SPTB. Importantly, these observations were conserved across two independent cohorts. Further, our data provide evidence for a persistent decrease in miRNA abundance in mothers who later experienced an SPTB, which is likely to have widespread consequences for gene regulation and epigenetic processes.

Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects.

Expression Profile of Maternal Circulating Micrornas As Non-Invasive Biomarkers for Prenatal Diagnosis of Congenital Heart Defects.

Integrative Analysis of Circulating Micrornas and the Placental Transcriptome in Recurrent Pregnancy Loss

Identification of Maternal Serum Micrornas As Novel Non-Invasive Biomarkers for Prenatal Detection of Fetal Congenital Heart Defects

Potential candidate maternal serum miRNAs for the diagnosis of fetal congenital heart disease

The Role in Pathomechanism and Diagnostic Significance

Complement factors and alpha‐fetoprotein as biomarkers for noninvasive prenatal diagnosis of neural tube defects

Profiling circulating microRNAs in maternal serum and plasma.

Potential role of maternal serum microRNAs as a biomarker for fetal congenital heart defects.

Quantification of Preeclampsia-Related Micrornas in Maternal Serum.

Differential Expression of Circulating Mirnas in Maternal Plasma in Pregnancies with Fetal Macrosomia

Serum exosomal coronin 1A and dynamin 2 as neural tube defect biomarkers

Bioinformatics-based Identification of Mirna-, Lncrna-, and Mrna-Associated Cerna Networks and Potential Biomarkers for Preeclampsia.

CORO1A and DNM2 in Serum Exosomes as Biomarkers of Neural Tube Defects

Application of Next-Generation Sequencing Technology to Profile the Circulating Micrornas in the Serum of Preeclampsia Versus Normal Pregnant Women

MicroRNA Expression Profiles and Networks in Placentas Complicated with Selective Intrauterine Growth Restriction.

A comprehensive survey of maternal plasma miRNAs expression profiles using high-throughput sequencing.

Maternal Plasma miRNAs as Early Biomarkers of Moderate-to-Late-Preterm Birth

Study on the differential expression of microRNAs in the preeclampsia serum

Metabolic Signature of Pregnant Women with Neural Tube Defects in Offspring.

Differential Expression Profile of Micrornas in Human Placentas from Preeclamptic Pregnancies Vs Normal Pregnancies